Meddings J B
Gastrointestinal Research Group, University of Calgary, Alberta, Canada.
Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:47-53; discussion 53-6. doi: 10.1111/j.1365-2036.1997.tb00808.x.
Measurements of intestinal permeability (IP) may help in determining susceptibility for the development of Crohn's disease or for imminent relapse in patients with the disease. It is now apparent that a subset of patients at high risk for the development of Crohn's disease have either increased baseline IP or an exaggerated response to environmental agents that increase IP. These, coupled with observations that increased IP in patients at risk for the development of Crohn's disease is associated with an abnormal immunological phenotype, lend support to the hypothesis that increased IP is a very early event in the genesis of Crohn's disease.
肠道通透性(IP)的测量可能有助于确定患克罗恩病的易感性或疾病患者即将复发的情况。现在很明显,一部分患克罗恩病高风险的患者要么基线IP增加,要么对增加IP的环境因素反应过度。这些情况,再加上有观察表明,患克罗恩病风险患者中IP增加与异常免疫表型相关,支持了IP增加是克罗恩病发病非常早期事件的假说。